China Medical System Holdings Limited (SGX:8A8)

SGX:8A8 Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,705	3,206	5,734	5,178	5,532	3,648
Market Cap Growth	79.74%	-44.09%	10.74%	-6.40%	51.65%	-24.09%
Enterprise Value	4,806	2,291	4,874	4,508	5,095	3,398
PE Ratio	19.45	10.58	12.83	8.17	8.64	7.12
PS Ratio	4.08	2.30	3.84	2.91	3.13	2.59
PB Ratio	1.87	1.05	1.98	1.81	2.03	1.62
P/TBV Ratio	2.43	1.38	2.62	2.45	2.95	2.38
P/FCF Ratio	35.00	13.87	12.44	7.54	10.55	6.79
P/OCF Ratio	33.70	13.52	12.31	7.50	10.45	6.69
EV/Sales Ratio	3.45	1.64	3.27	2.53	2.88	2.42
EV/EBITDA Ratio	12.21	6.50	8.96	6.17	7.15	5.67
EV/EBIT Ratio	13.89	7.42	9.65	6.53	7.62	6.07
EV/FCF Ratio	29.49	9.91	10.58	6.56	9.72	6.32
Debt / Equity Ratio	0.04	0.05	0.09	0.12	0.13	0.06
Debt / EBITDA Ratio	0.39	0.45	0.45	0.48	0.51	0.20
Debt / FCF Ratio	0.82	0.70	0.53	0.51	0.69	0.23
Net Debt / Equity Ratio	-0.30	-0.30	-0.31	-0.28	-0.21	-0.19
Net Debt / EBITDA Ratio	-2.75	-2.65	-1.65	-1.08	-0.79	-0.70
Net Debt / FCF Ratio	-5.69	-4.05	-1.95	-1.15	-1.07	-0.78
Asset Turnover	0.42	0.42	0.45	0.55	0.59	0.58
Inventory Turnover	3.14	2.91	3.48	4.45	4.90	4.60
Quick Ratio	5.12	5.10	3.89	2.79	3.22	4.89
Current Ratio	5.78	5.74	4.29	3.07	3.55	5.46
Return on Equity (ROE)	9.90%	10.10%	15.74%	23.75%	25.26%	24.79%
Return on Assets (ROA)	5.58%	5.77%	9.56%	13.23%	13.82%	14.47%
Return on Invested Capital (ROIC)	11.27%	11.97%	21.03%	29.64%	28.68%	28.02%
Return on Capital Employed (ROCE)	9.60%	10.00%	17.30%	23.90%	23.00%	23.40%
Earnings Yield	5.14%	9.45%	7.79%	12.24%	11.58%	14.04%
FCF Yield	2.86%	7.21%	8.04%	13.27%	9.48%	14.73%
Payout Ratio	23.07%	34.34%	56.66%	39.16%	38.27%	32.96%
Buyback Yield / Dilution	1.13%	1.00%	0.08%	0.56%	0.17%	0.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.